Frequency of Erectile Dysfunction after Transurethral Resection of Prostate
DOI:
https://doi.org/10.52206/jsmc.2022.12.3.692Abstract
Background: The most effective treatment for symptomatic benign prostatic hyperplasia is surgery. When a patient is diagnosed with BPH and surgery is scheduled, the urologist will usually do transurethral resection of the prostate (TURP) to alleviate symptoms due to its positive results. The effect of TURP on sexual function, on the other hand, is yet unknown and debated.
Objective: The purpose of this study was to determine the incidence of ED in sexually active adult males.
Materials and Methods: The following are the materials and procedures that were used to complete this project. A total of 165 individuals between the ages of 40 and 65 years old with LUTS symptoms were included in the study. Patients with uncontrolled diabetes, a big prostate, bladder stones, or complicated urethral illness, such as corrected hypospadia or repaired urethral stricture disease, were excluded from the study. Every patient had TURP surgery and was cared for according to our ward routine until he was discharged.
Results: The study's participants ranged in age from 40 to 65, with a mean age of 57.50 3.10 years. The majority of the 114 patients (69.09%) were between the ages of 56 and 65. Pre-operative IIEF-5 scores were 18.53 5.24, while post-operative IIEF-5 scores were 15.06 2.50. Patients with ED following TURP were observed in 29 (17.58%) of sexually active adult males, with mild ED in 13 (44.83%), moderate ED in 09 (31.03%), and severe ED in 07 (24.14%).
Keywords: benign prostatic hyperplasia, transurethral resection of prostate, erectile dysfunction.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.



